Ionis Pharmaceuticals Inc (NAS:IONS)
$ 35.91 -0.42 (-1.16%) Market Cap: 5.74 Bil Enterprise Value: 4.73 Bil PE Ratio: 0 PB Ratio: 8.65 GF Score: 40/100

Ionis Pharmaceuticals Inc Annual Shareholders Meeting Transcript

Jun 06, 2019 / 09:10PM GMT
Release Date Price: $63.49 (-4.19%)
Stanley T. Crooke
Ionis Pharmaceuticals, Inc. - Founder, Chairman, CEO & President

Good afternoon, and welcome to 2019 Meeting of Ionis Shareholders.

I will be making forward-looking statements. They are associated with risks, so you're encouraged to consider both the risk and the opportunity as you think about Ionis.

This year, at Ionis, we are celebrating our 30th anniversary. We opened the doors to our first facility in March of 1989, and this actually is a picture of our first facility. We had a door. There it is. We also had a window and a sign and there they are.

So for those of us who have participated, this has been a remarkable journey. But for me, what makes the journey extraordinary is that where we are today is simply the end of the beginning. And the most important thing we've accomplished is we've laid the foundation for an even more exciting future.

And so today, of course, I'll present a solid summary of where the company stands today, with a particular focus on what we've accomplished in the last -- since the last annual meeting. And then I'll

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot